Large-scale testing (Phase 3)Study completedNCT03619213
What this trial is testing
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
Who this might be right for
Heart Failure With Preserved Ejection Fraction
AstraZeneca 6,263